Remuneration

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, August 9, 2022 - 2:00am
Legal, Professional Services, P.C, Telephone, Anti-Kickback Statute, SEC, DOJ, Securities Exchange Act of 1934, Remuneration, Genetics, Battle of Saint-Fulgent, Company, Exchange, NASDAQ, Jeanne Eagels, News, Stark, Private investigator

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.
  • Our investigation concerns whether Fulgent has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Fulgent released its financial results for the second quarter of 2022 on August 4, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bioasis Technologies Inc. Announces Stock Option Grants

Retrieved on: 
Monday, August 8, 2022 - 10:47pm
Company, BTI, Board, Director, Therapy, Central nervous system, Xbox, Remuneration, Traffic barrier, GLOBE, Pharmaceutical industry, Holding company, HAVEN

NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC .

Key Points: 
  • NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC .
  • All of the options expire five years from the date of the grant and are governed by the terms of the companys stock option plan.
  • The options are being issued as part of annual remuneration.
  • On behalf of the Board of Directors of Bioasis Technologies Inc.

Amundi Asset Management: Final Terms

Retrieved on: 
Monday, August 8, 2022 - 5:06pm
Movement, Settlement, Redemption, Euronext Amsterdam, Metal, Investment, Total expense ratio, Human, Program, Business Day, Silver, Sale, President's Pay Agent, Subscription business model, Euronext Paris, Custody, Tax, Trustee, Business, HSBC Bank (Europe), London, HSBC Bank, United Kingdom, Prospectus, Security (finance), Interest, Base, ETC, LBMA, VAT, Settlement date, London Bullion Market Association, S.A.S, Application, Remuneration, Calendar, London Stock Exchange, Service, Arrangement, USD, Financial adviser, Bank, Amusement arcade, Lease, Life insurance, Risk management, Deutsch, Issuer, Adviser, Series, Participation, Custodian, Gold, National identity cards in the European Economic Area

Each ETC Security relates to a specific amount in weight of Gold, specified in the Final Terms, known as the Metal Entitlement.

Key Points: 
  • Each ETC Security relates to a specific amount in weight of Gold, specified in the Final Terms, known as the Metal Entitlement.
  • Payment of any Early Redemption Amount or the Final Redemption Amount is subject at all times to the limited recourse provisions.
  • Any early or final redemption of the ETC Securities of a Series will be settled in cash.
  • Amundi Asset Management S.A.S.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

Retrieved on: 
Monday, August 8, 2022 - 5:00pm
Class Action Lawsuit, Professional Services, Legal, FDA, Press, Real estate investment trust, Industry, Associated Press, Anti-Kickback Statute, SEC, DOJ, Investment, Securities Exchange Act of 1934, GPM, SCAS, Remuneration, Information technology, Battle of Saint-Fulgent, Genetics, U.S. Department of Justice Office of Legislative Affairs, U.S. Department of Commerce Office of Security, Company, Person, Program, NASDAQ, Exchange, Bloomberg Businessweek, Publication, News, Financial Times, Insurance, Stark, The Wall Street Journal, Justice, Pharmaceutical industry, Reuters, Forbes

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, Fulgents stock fell as much as 8% during intraday trading on August 5, 2022, thereby injuring investors.
  • Whistleblower Notice: Persons with non-public information regarding Fulgent should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Monday, August 8, 2022 - 2:22pm
Class Action Lawsuit, Professional Services, Legal, Suite, Anti-Kickback Statute, SEC, DOJ, Securities Exchange Act of 1934, Remuneration, Genetics, Battle of Saint-Fulgent, Company, Exchange, NASDAQ, News, Ethics, Stark, Certification, Security (finance)

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • Fulgent released its financial results for the second quarter of 2022 on August 4, 2022.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

MD Medical Group Investments Plc: MD Medical Group announcement of the extraordinary general meeting

Retrieved on: 
Monday, August 8, 2022 - 10:02am
Joint-stock company, Board, Director, Annual, MOEX, Remuneration, Company, Mission statement, Investment, LSE, Łapino, Board of directors, The Harley Medical Group, MAR, Russia, Health insurance, Odintsovsky

MD Medical Group Investments Plc: MD Medical Group announcement of the extraordinary general meeting

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group announcement of the extraordinary general meeting
    Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • The record date to participate the Annual General Meeting of shareholders shall be 08 August 2022.
  • For further information please contact:

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 8, 2022 - 2:00am
Class Action Lawsuit, Professional Services, Legal, P.C, Telephone, Anti-Kickback Statute, SEC, DOJ, Securities Exchange Act of 1934, Remuneration, Genetics, Battle of Saint-Fulgent, Company, Exchange, NASDAQ, Jeanne Eagels, News, Stark, Private investigator

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.
  • Our investigation concerns whether Fulgent has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Fulgent released its financial results for the second quarter of 2022 on August 4, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Friday, August 5, 2022 - 10:28pm
Professional Services, Class Action Lawsuit, Suite, Anti-Kickback Statute, SEC, DOJ, Securities Exchange Act of 1934, Remuneration, Genetics, Battle of Saint-Fulgent, Company, Exchange, NASDAQ, News, Ethics, Stark, Certification, Security (finance)

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • Fulgent released its financial results for the second quarter of 2022 on August 4, 2022.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

Retrieved on: 
Friday, August 5, 2022 - 10:00pm
Class Action Lawsuit, Professional Services, Legal, Telephone, Suite, Anti-Kickback Statute, SEC, Securities Exchange Act of 1934, Remuneration, Genetics, Battle of Saint-Fulgent, U.S. Department of Justice Office of Legislative Affairs, Privacy Office of the U.S. Department of Homeland Security, Company, Exchange, NASDAQ, News, Stark, Justice, Private investigator

Law Offices of Howard G. Smith announces an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of federal securities laws.
  • On August 4, 2022, Fulgent released its second quarter 2022 financial results, disclosing that the SEC is conducting an investigation into certain Exchange Act reports for 2018 through the first quarter of 2020.
  • On this news, Fulgents stock fell as much as 8% during intraday trading on August 5, 2022, thereby injuring investors.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

Retrieved on: 
Friday, August 5, 2022 - 8:10pm
Class Action Lawsuit, Professional Services, Legal, Suite, Anti-Kickback Statute, SEC, Securities Exchange Act of 1934, Law, Remuneration, Genetics, Battle of Saint-Fulgent, U.S. Department of Justice Office of Legislative Affairs, Privacy Office of the U.S. Department of Homeland Security, Company, Twitter, Exchange, NASDAQ, News, Stark, Justice, Online gambling

The Law Offices of Frank R. Cruz announces an investigation of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) on behalf of investors concerning the Companys possible violations of federal securities laws.

Key Points: 
  • The Law Offices of Frank R. Cruz announces an investigation of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) on behalf of investors concerning the Companys possible violations of federal securities laws.
  • On August 4, 2022, Fulgent released its second quarter 2022 financial results, disclosing that the SEC is conducting an investigation into certain Exchange Act reports for 2018 through the first quarter of 2020.
  • On this news, Fulgents stock fell as much as 8% during intraday trading on August 5, 2022, thereby injuring investors.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.